Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 8624257 | 8623364 | F | 8624257-6 | 20120516 | 20120815 | 20120827 | EXP | US-JNJFOC-20120607999 | JANSSEN PRODUCTS, LP | 18 | YR | F | Y | 20120827 | OT | UNITED STATES |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 8624257 | 1020672923 | PS | PREZISTA | 1 | ORAL | 21976 | |||||
| 8624257 | 1020672925 | SS | RITONAVIR | 1 | ORAL | ||||||
| 8624257 | 1020672926 | SS | ISENTRESS | 1 | ORAL | ||||||
| 8624257 | 1020672927 | SS | EPZICOM | 1 | ORAL | ||||||
| 8624257 | 1020672924 | SS | ETRAVIRINE | 2 | ORAL | 022187 |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 8624257 | 1020672923 | HIV INFECTION |
| 8624257 | 1020672925 | HIV INFECTION |
| 8624257 | 1020672926 | HIV INFECTION |
| 8624257 | 1020672927 | HIV INFECTION |
| 8624257 | 1020672924 | HIV INFECTION |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 8624257 | HO |
Reactions reported
| Event ID | PT |
|---|---|
| 8624257 | AMNIOTIC FLUID VOLUME DECREASED |
| 8624257 | MATERNAL EXPOSURE DURING PREGNANCY |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 8624257 | 1020672923 | 20111115 | 20120516 | ||
| 8624257 | 1020672925 | 20111115 | 20120516 | ||
| 8624257 | 1020672926 | 20111115 | 20120516 | ||
| 8624257 | 1020672927 | 20111115 | 20120516 | ||
| 8624257 | 1020672924 | 20111115 | 20120516 |